Pfizer Selects ChemAxon’s Markush Platform

22 Jan 2010
Sarah Sarah
Marketing / Sales

ChemAxon has entered into agreement with Pfizer to provide its Markush searching and structure enumeration functionality for global development and deployment within Pfizer’s global R&D facilities.

“Markush structure search and enumeration is becoming of critical importance for structure IP and patent development.” said Alex Drijver, CEO of ChemAxon. “It is an area where ChemAxon has developed a high area of expertise and where we are moving very much into the forefront.”

Links

Tags